معرفی
Dr. Stephanie Hirschbichler is a neurologist and researcher at the Department of Neurology at St. Pölten University Hospital, affiliated with Karl Landsteiner Private University. She serves as head of the Movement Disorders Outpatient Clinic and is actively involved in both clinical care and research. Her work bridges neuroscience, neurology, and digital health innovation, with a focus on Parkinson’s disease and movement disorders.
- Medical University of Graz – Medical Degree
- University College London (UCL) – MSc in Clinical Neurology, PhD
Her research focuses on dopamine’s role in behavior, motor control, and decision-making, particularly in Parkinson’s disease. She investigates risk tolerance, device-assisted therapies, and virtual reality-based rehabilitation. Her clinical and research work is closely integrated, enabling translational applications in patient care.
Her recent publications explore deep brain stimulation’s effects on decision-making, clinical neurophysiology of tremor, and autonomic symptoms in Parkinson’s. These studies reflect her expertise in combining electrophysiology, behavioral tasks, and neuroimaging to understand motor and non-motor aspects of movement disorders.
She is currently leading or involved in several research projects, including:
- PD_VR: Delineating motor and non-motor aspects of Parkinson’s disease
- VReeze: Virtual reality-based assessment of freezing of gait
- DOPA: Dopamine’s effects on motor and cognitive control (completed)
She teaches at the Medical University of Graz and Karl Landsteiner Private University and is working toward her habilitation. She collaborates with the Center for Digital Health and Social Innovation (CDHSI) at St. Pölten University of Applied Sciences, integrating digital tools into neurorehabilitation.
Dr. Hirschbichler supervises no students listed in the provided texts and has not been awarded any specific scientific prizes mentioned. Her clinical and research leadership reflects a strong commitment to advancing patient-centered neuroscience and innovative therapeutic approaches.
